VERQUVO cpr pell 2.5 mg 14 pce
7680680010013
CH-68001
C01DX22
02.07.1.
Reimbursement limitations:
VERQUVO
Pour le traitement des patients adultes présentant une insuffisance cardiaque chronique symptomatique de classes NYHA …
1 / 3
google
Details
- Product number
- 6800101
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- Filmtablette: vericiguatum 2.50 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 61.20 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, talcum, E 171, pro compresso obducto corresp. natrium 0.80 mg.
Articles (1)
Verquvo 2.5 mg, Filmtabletten
Filmtabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
FTAB
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
61.2 MG | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | HNIDK |
|
FTAB
|
- | Substance | FNIDK |
|
FTAB
|
0.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 54.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2023
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 68001
- Drug name
- Verquvo, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C01DX22
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/09/2021
- Authorization expiration date
- 21/09/2026
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VERQUVO cpr pell 2.5 mg 14 pce
- Description (DE)
- VERQUVO Filmtabl 2.5 mg 14 Stk
- Market launch
- 22/09/2021
- Narcotic (BTM)
- No